Posts Tagged ‘deficit reduction’

Super Committee Failure: It Could Have Been Worse!

Wednesday, November 23rd, 2011

Late Monday, the 12 members of the Joint Select Committee on Deficit Reduction (aka the “Super Committee”) announced their failure to agree to a debt-reduction package. How should consumer health advocates react to the news?

A Plague on Only One of Your Houses
“He said/she said” media accounts suggest that the Super Committee failed because the Republicans rejected any meaningful revenue increases and because Democrats were equally obstinate in refusing to cut entitlement programs, such as Medicare and Medicaid.

The truth is that Committee Democrats were willing (far too willing in our view) to consider ill-advised and unnecessary cuts to Medicare benefits and to Medicaid. For example, one of their final proposals involved $50 billion in Medicaid cuts, including a $13 billion reduction in the federal-matching dollars that help states fund the program. It also cut $350 billion from Medicare, including $100 billion from beneficiaries – most likely by imposing higher premiums and co-pays.

Republicans did not offer equivalent concessions on revenues. Their proposal included a largely regressive revenue increase: caps on tax expenditures, such as the tax exemption on employer-sponsored health insurance. And it squandered most of these new revenues paying for an income tax cut that would lock us into rates well below the Bush tax cut levels, largely to the benefit of the highest-income earners.

Reports suggest that a last-ditch effort at a deal failed because not one Super Committee Republican would agree to even a nominal tax hike on the wealthiest Americans. Democrats – to their credit – drew the line at asking low- and moderate-income Americans to bear the entire brunt of deficit-reduction.

A Mixed Bag for Health Care
The failure of the Super Committee to come up with a deficit-reduction package triggers across-the-board cuts, starting in 2013. These cuts are designed to achieve $1.2 trillion in savings over 10 years – half in defense spending and half in domestic spending.

Fortunately, many important health care programs are exempt from these cuts, including Medicaid, the Children’s Health Insurance Program (CHIP), and the premium tax credits that are slated to help families in the Exchange starting in 2014. Medicare benefits are also largely protected: across-the-board cuts to Medicare are limited to two percent of the programs’ costs, and can only come from cuts to providers and insurers.

But not all health care spending is protected. The sequester will increase low- and moderate-income families’ out-of-pocket health care costs starting in 2014 by cutting into the cost-sharing subsidies in the Exchange. Cuts will also impact Basic Health Program funding, threatening the viability of a program that has great potential to lower health care costs for very low-income families. And they will restrict funds for the Public Health and Prevention Fund, undermining its potential to improve the health of the American people. In addition the cuts in the sequester are expected to have a negative impact on employment, meaning fewer people with employer sponsored insurance and more people either uninsured or on Medicaid.

A silver lining?
One possible silver lining to the across-the-board Medicare cuts triggered by Super- Committee failure is that they could open the door to improvements in our payment system.

Billions of dollars every year are wasted on preventable hospital admissions and complications, such as hospital-acquired infections. The Affordable Care Act begins to tackle this problem by reducing payments to hospitals with high rates of preventable readmissions and complications, but much more remains to be done.

Rather than relying on across-the-board rate cuts to achieve the necessary savings in Medicare, policymakers could target cuts at providers with higher levels of this type of preventable health care spending. This would translate to better care for patients as well as lower cost for the system, and gives providers a chance to reduce costs by improving quality instead of just having to absorb another rate cut. Better care at lower cost is also a better alternative than the benefit cuts that were considered by the Super Committee and would put Congress on the side of the American people, who want to see Medicare and Medicaid protected, not gutted.

As Yogi Berra would say, “it Ain’t over ‘til it’s over” (and it Ain’t over)
Although the Super Committee has closed its case, advocates cannot rest easy. Congress is headed straight into another spending battle that puts health care funding at risk yet again.

Health care industry analysts had hoped the Super Committee’s deal would fix the Sustainable Growth Rate (SGR), a broken formula that automatically reduces Medicare physician payment rates every year. The failure of the Super Committee to reach a deal means Congress has only five weeks to override the scheduled 27 percent Medicare physician payment cut required by the SGR formula, and they are likely to look to savings in health care programs to foot the bill.

To pay for last year’s SGR fix, Congress weakened the ACA’s affordability protections for low- and moderate-income families. It’s entirely possible that bad ideas bandied about by the Super Committee will be back on the table as potential pay-fors for this year’s SGR fix. So advocates need to take a deep breath, and get ready to fight once more to protect these vital programs.

-Katherine Howitt, Senior Policy Analyst
and Michael Miller, Strategic Policy Director

Deficit Reduction 101: Follow the Money

Friday, September 23rd, 2011

When it comes to prescription drugs, President Obama’s deficit-reduction plan follows Willy Sutton’s famous advice to “go where the money is.” Of the proposed $580 billion in total savings over 10 years, more than a quarter comes via three important proposals targeting the high cost of prescription drugs.

The biggest chunk of savings, worth $135 billion – nearly a fourth of the President’s total –would come from extending drug rebates to the ‘dual eligible’ population — primarily low-income seniors or people with disabilities — who qualify for both Medicare and Medicaid. This change would reverse the multi-billion dollar windfall that drug companies received when drug benefits for these patients were shifted out of Medicaid under Medicare Part-D implementation in 2006.

In a 2008 report, the House Committee on Oversight and Government Reform reported that in the first two years under Medicare Part-D, drugmakers had made $3.7 billion more by avoiding rebate payments for these dually eligible patients. Rep. Henry Waxman (D-CA) stated “This is an enormous giveaway…and it has absolutely no justification. The drug companies are making the same drugs. They are being used by the same beneficiaries. Yet because the drugs are being bought through Medicare Part D instead of Medicaid, the prices paid by the taxpayers have ballooned by billions of dollars.”

Two other proposals in Obama’s plan — a ban on pay-for-delay drug deals, and a reduction of the exclusivity period for brand-name biologics — aim to reduce costs by promoting a more competitive marketplace.

The Federal Trade Commission (FTC) and leaders in Congress have championed a ban on pay-for-delay settlements, the sweetheart deals where brand name drug makers pay their competitors to delay selling a generic version of their drug. FTC Chairman Jon Leibowitz applauded the inclusion of a pay-for-delay ban in the White House’s deficit reduction proposal. “Curbing anticompetitive pay-for-delay deals in the pharmaceutical industry…would reduce the deficit by billions of dollars over the next decade without raising taxes or cutting critical programs,” he said. “This should be a painless choice for the deficit reduction committee.”

And Obama’s proposal to reduce brand-name “biologic” exclusivity from 12 to seven years is also sensible. Biologic drugs, made through a biologic rather than chemical process, can be complex medicines that patients desperately need. But they can also be extremely expensive, costing hundreds of thousands of dollars a year for the treatment of a single patient. Allowing competition from generic versions to start five years earlier could yield significant savings, while also helping improve patient access to needed medicines.

Not surprisingly, the brand-name drug industry has opposed these proposals. First, they warned that extending the drug rebates could cause job losses in their industry, undermining in some way the benefits of deficit reduction. They must be hoping the public will overlook the many-year trend to relocate manufacturing and research jobs overseas — the industry’s business model in search of lax or non-existent regulatory standards coupled with cheap labor. But it’s hard to miss given that the drug industry has led all sectors in lay-offs as recently as this past July, for this and other reasons.

But assuming we were fooled and bought the argument, how should the public respond? Is it good policy to waste public dollars by letting an industry charge one government program millions more than another program? Obviously not.

But reclaiming and redirecting dollars wasted on an inflated pharmaceutical industry could increase our public investment in science research, creating science and research jobs, keeping us competitive in the global economy, and promoting patient’s long-term interests in finding new cures.

– Marcia Hams, Director Prescription Access and Quality
– Wells Wilkinson, Director Prescription Access Litigation

A Health Advocate’s Guide to the Debate on Deficit and Debt Reduction

Monday, December 13th, 2010

Recently, a blizzard of deficit and federal debt reduction plans has emerged from across the political spectrum. Many of them—especially those coming from the center/right—propose major changes in the benefits and/or financing of Medicare and Medicaid in the name of getting the nation’s “fiscal house in order” and restoring economic growth.

For different reasons and in different contexts, these public insurance programs already have been getting some rough treatment in public debate.

For Medicare, the recent context has included continuing debate over cost containment provisions in the Affordable Care Act—a debate that includes allegations of death panels, rationing, and the forcing of seniors onto “government-controlled” health care. (Note: It doesn’t have to make sense; it’s just a sound bite.)

For Medicaid, the challenge has rested mainly at the state level. Cash-strapped states have struggled to keep up with increased demand for Medicaid amidst falling revenue streams and other realities arising from the recession. Many states have filed suits to block the ACA-mandated expansion of Medicaid eligibility. Some have gone so far as to threaten withdrawal from the Medicaid program.

However, as a new political alignment prepares to take the reins in Washington, new federal level threats are aimed against Medicare and Medicaid, which form the foundation of our nation’s health care safety net, particularly for older adults, people with disabilities and children. The deliberations of the official Deficit Reduction Commission (DRC) appointed by President Obama, along with related policy proposals, such as the one released by the Bipartisan Policy Center (an organization financed by Peter G. Peterson – a long-term proponent of reduced federal spending on entitlement programs), bring these threats into focus.

Putting the Deficit Debate into Context
As Henry Aaron of the Brookings Institution observed in the New York Times, the various official and unofficial “commission” reports aim at three distinct problems: the short-term increase in the national debt, a projected shortfall in Social Security funds, and a projected long-term rise in the national debt. Let’s look at the short- and long-term issues in turn.

It’s the economy, stupid (and the wars and the Bush tax cuts)
Most economists agree that the current short-term increase in public debt is attributable almost entirely to the wars in Afghanistan and Iraq, the Bush tax cuts (mainly benefiting the wealthy) and the recession. Also, lingering effects of the recession, not health spending or the debt, pose the most immediate and serious threat to our health security and general well-being. Persistent high unemployment rates reduce the proportion of people who have employer-sponsored health insurance, and also reduce the revenue to fund Medicare, Medicaid and Social Security while driving Medicaid enrollment up. With enhanced federal support for Medicaid slated to expire in June even while states face continued significant revenue shortfalls, pressures on Medicaid will be greater than ever.

Meanwhile, the actions and words of President Obama’s financial advisors make it clear that they do not regard the possibility of a “double dip” recession as being out of the question, especially without additional fiscal stimulus. By spurring job growth, additional stimulus would support the economic recovery and restore growth, creating the conditions necessary to bring down the short-term debt. Reducing unnecessary military spending and restoring more progressivity to the tax code also would help. However, the type of stimulus that would include additional federal funds for state Medicaid programs appears to be off the table.

Medicare and Medicaid in the crosshairs
Finally, and most significantly for health care advocates, the various commission reports all addressed the issue of long-term projected increases in Medicare and Medicaid spending. The CBO has projected that the growth of federal debt long-term is attributable almost entirely to the growth of health care spending, particularly Medicare and Medicaid. Based on this, various debt-buster report recommendations to reduce health care spending in Medicare and Medicaid vary from the benign (increasing funds for fiscal oversight, reducing fraud and payment errors, and collecting the Medicaid drug rebate for all dual-eligibles) to the alarming (increasing Medicare cost-sharing, setting a global cap on federal health spending equal to GDP growth plus one percent, turning Medicare into a voucher program, and eliminating the federal commitment to matching state Medicaid spending on no less than a dollar for dollar basis).

Beware of GIGO (Garbage In Garbage Out)
Before entertaining any drastic action to cut Medicare and Medicaid, policymakers should subject the assumptions underlying the Deficit Reduction Commission and similar reports to careful scrutiny. First, although you would never know it from any of these reports, there is actually very little evidence to support any particular debt-to-GNP ratio as a target that we must adhere to or risk financial disaster. (See this and this for discussions that call into question the basic premises of the deficit commission. An opposing view is here.)

Policymakers also should closely examine underlying assumptions in the CBO forecast. Projections of explosive debt growth are very sensitive, both to assumptions and to policy change. (See, for example, the difference between the 2009 and 2010 CBO forecasts.) James Galbraith and others have pointed out that the CBO baseline assumes an unlikely combination of circumstances that includes low inflation (except in health care) and, notwithstanding that low inflation rate, significantly higher interest rates. CBO also assumes that there are no long-term cost savings effects from the ACA. While it may be prudent not to assume a continuing cost-containment effect from the ACA, it also would be prudent to give the law a chance to work before performing radical surgery on the core of our health care safety net.

Finally, neither the assumed need for debt reduction nor the use of arbitrary caps to reduce the percentage of our economy devoted to Medicare and Medicaid are helpful lenses through which to consider the question of health care cost containment. On the one hand, reduction of the debt is taken as a primary good, with benefits assumed but not demonstrated. On the other hand, discussion of the impact of proposed cuts on health programs serving older adults and others served by Medicare and Medicaid is nowhere in evidence. It is impossible to judge the reasonableness of proffered recommendations without looking at their costs, as well as any alleged benefits.

A few facts are important to keep in mind:

– Medicare already offers coverage benefits that are less generous than those typically available through employer-sponsored insurance.
– Older adults already devote a substantial share of their income to health care –well above what younger groups spend.
– Medicaid beneficiaries are both the poorest and sickest members of society. A retrenchment in Medicaid is therefore likely to create substantial hardship both for the low-income frail seniors and younger adults and children with chronic illnesses and disabilities on whom most Medicaid dollars are spent.
– The same proposals that envision reducing the value of Medicare also envision reducing Social Security benefits, creating a double whammy for all who do not participate fully in the labor force because of old age, disability or other categorical dependency.

The cost of public programs providing health coverage and services is tied to the overall growth in health care costs. Focusing only on public spending in this equation obscures this link and leads toward draconian solutions that harm vulnerable populations rather than smarter, more system-wide approaches. Arbitrary cuts in public spending for health care would be a cure worse than the disease. What we need is not an arbitrary cap on health spending, but long-term integrated approaches to reducing the rate of growth in health care costs that also improve quality and value. The Affordable Care Act plants the seeds of such a program. More could be done, but that will require less demagoguery and ideological rigidity than was on display during the debate on passage.

Is the threat real?
For now, the debt reduction juggernaut may be temporarily stalled. Even Congress might blush before recommending major cuts to popular programs immediately after voting to increase the deficit by $900 billion, as they are now considering doing. But it is not dead. When the debate turns again to debt reduction, it is critically important for advocates of quality affordable health care for all to block a stampede caused by debt-phobia that would undermine health security for millions of Americans.

– Michael Miller, Policy Director

Fighting the good fight: Two tools to help get reform done

Wednesday, January 27th, 2010

Though health care reform has always been subject to the political tides, the political and legal challenges to reform legislation and its successful passage are rising. As supporters of reform who work with great advocates around the country,  we’re rising too (to the occasion) — here are two tools to help your reform work right now:

Making the economic case for health care reform

Sure, the Senate health care reform bill will help families save between $500 and $7000 a year on health insurance premiums, will limit out-of-pocket costs, and will cover 31 million uninsured people — Old News! But did you know the Senate bill is also good for the Economy? This fact sheet tells why. Download and share it.

Fighting the legal challenges facing national reform

And while the federal debate moves ahead, reform opponents in the states are already mounting constitutional and legislative challenges. Our new paper looks at these legal challenges and their political context, and offers talking points and organizing suggestions to respond, so you’ll be ready for Law & Order: Health Care Reform Unit!


–Kate Petersen,  Health Policy Hub